Saturday, November 23, 2024
11/23/2024
Project Summary/Abstract We request partial support for the Hemostasis Gordon Research Seminar (GRS) and Gordon Research Conference (GRC) held from August 3-9, 2024, in Waterville Valley, NH. The 2024 Hemostasis GRC is the 36th meeting in this series which is widely considered as the premier scientific meeting for hemostasis and thrombosis research. The GRC/GRS fulfills the mission of the NHLBI in several important ways. First, the Hemostasis GRS/GRC is an extremely important forum in the blood science arena in which the latest unpublished research is presented and major advances in the field are unveiled. The meeting brings together researchers interested in the biology, biochemistry, and genetics of blood clotting proteins and platelets; physicians treating bleeding and thrombotic diseases, scientists from pharmaceutical companies developing new therapies for hemostatic disorders. Seminal discoveries in hemostasis and thrombosis and allied fields have stemmed from interactions originating at this conference. Free exchange of ideas and unpublished research, among all attendees, is a key to the success of our programs. Second, emphasis of this conference on young and emerging investigators to ensure the long-term sustainability of the blood science workforce. As such, the hemostasis GRC is preceded by the GRS, a two-day program exclusively focused on trainees who are committed to research careers in hemostasis and thrombosis. The GRS is organized and run by trainees. Third, and a major priority of the 2024 Hemostasis GRS and GRC programs, is to increase the diversity of participation by speakers and attendees. Starting from the diverse composition of the leadership team, including the GRC Chair (Dr. Arepally)/Co-Chair (Dr. Washington) and GRS Chair (Dr. Branfield) to the invited speakers/session leaders (including 38% junior/emerging investigators, ~33% female investigators and 20% under-represented minorities) and a dedicated session (GRC Powerhour) focused on issues of diversity/equity/inclusion, next year’s program will establish a template for organizing future conferences as well as empower attendees to address racial barriers and inequities at their home institutions. The 2024 Hemostasis GRC program features a Keynote Session on lessons learned from the COVID19 Pandemic (The Pandemic: Looking Back & Moving Forward) and will be given by two prominent physician scientists, Dr. Jeffrey Berger and Dr. Matthew Neal, who were at the forefront of leading basic and clinical investigations. The 8 oral and 4 poster sessions focus on topics highly-relevant to hemostasis/thrombosis research including sessions on emerging concepts and tools (“Advancing Frontiers in Hemostasis”), in vitro and in vivo models of hemostasis (“Hemostasis: Models & More”), thrombotic disorders (“Clotting Gone Awry”), fundamental mechanisms (“Hemostasis: Inside & Out”), vascular biology (“Blood in Motion), structural studies (“Structure Meets Function”) and the biochemical basis of coagulation (“The Ties that Bind Us”). Finally, we will continue to hold the “Hot Topics” session of Abstract Talks during which 8 trainees present their work orally.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
